Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in
cancer patients ... ball-and-stick model.png. Clinical data. Trade names, Mozobil.
Official site from Genzyme Corporation. Contains consumer and prescribing
Mozobil (plerixafor injection) is approved by the United States Food and Drug
Administration (FDA) to be used with another agent, granulocyte-colony ...
Learn how you can order and be reimbursed for Mozobil (plerixafor injection).
Please see Important Safety Information.
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that
can be collected and transplanted back. Learn about side effects, interactions ...
Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale
yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...
Aug 27, 2015 ... Find a comprehensive guide to possible side effects including common and rare
side effects when taking Mozobil (Plerixafor Injection) for ...
MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ...
Initiate Mozobil treatment after the patient has received G-CSF once daily for 4
Medscape - Indication-specific dosing for Mozobil (plerixafor), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Mozobil 20 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE
COMPOSITION. One ml of solution contains 20 mg plerixafor. Each vial contains